COMMUNIQUÉS West-GlobeNewswire
-
Dank Cannabis Highlights Free Delivery Across Alberta, With Same-Day Service Until Midnight
29/09/2026 -
20/20 BioLabs to Host Investor Webinar on October 7, 2026 to Discuss FDA Advisory Committee Vote and New OneTest™ Franchise Model
29/09/2026 -
Kraig Labs Takes Biggest Step Yet and Ships First Commercial Spider Silk Order, as Performance Brand Set to Put Breakthrough Fiber to the Test
29/09/2026 -
SeaStar Medical Announces Chief Medical Officer, Kevin Chung, M.D., to Present at the Pediatric Paracorporeal and Extracorporeal Therapy Symposium (PPETS) 2026
29/09/2026 -
Moleculin Biotech Completes Enrollment in Part A of Phase 2/3 R/R AML MIRACLE Trial, Keeping Program on Track for Q1 2027 Data Readout
29/09/2026 -
Tria Federal Awarded Four-Year, $120M Contract to Support VA's Veterans Community Care Program
29/09/2026 -
Vivos Therapeutics Reports Progress in Material Cost Reductions and Revenue Growth Initiatives
29/09/2026 -
NeOnc’s Powerful Brain Cancer Pipeline Advances
29/09/2026 -
H1 Selected by CMS to Help Build a Trusted National Foundation for Provider Information
29/09/2026 -
With Fusion™ Denture Family, Dandy Sets a New Standard of Care
29/09/2026 -
10X Health Earns NSF Certified for Sport® Certification for its 10X Creatine and 10X Amino Blend Products
29/09/2026 -
Nexalin Technology Taps Neuromodulation Commercial Executive Robert DiTota to Advise on its Global Commercialization Strategy
29/09/2026 -
Tiny Health Raises $33M Series B to Establish Microbiome Intelligence as the Standard of Care
29/09/2026 -
Liminatus Pharma Regains Compliance with Nasdaq Minimum Bid Price Rule
29/09/2026 -
TETmedical Names Arjun Ishwar Chief Commercial Officer to Lead Commercial Strategy and Accelerate NSE-FAST® Toward Market Launch and Rapid Growth
29/09/2026 -
Standard Dental Labs Files Semiannual Report and Projects Annualized Revenue of 3.48 Times 2025 Revenue
29/09/2026 -
Simone Biles Partners with Arcutis to Launch the Skin to Believe In Campaign, Raising Awareness of Seborrheic Dermatitis and Eczema, and Inspiring People to Explore Treatment Options
29/09/2026 -
SafeSpace Global Advances Addiction Treatment Vertical with Signed Statement of Work and Initial Antidote Health Ventures Deployment
29/09/2026 -
Ernexa Therapeutics Selected for Emerging Track at 2026 Cell & Gene Meeting on the Mesa, Highlighting ERNA-101 and Focused Oncology Strategy
29/09/2026
Pages